2014
DOI: 10.1038/srep07072
|View full text |Cite
|
Sign up to set email alerts
|

Multifunctional Core/Shell Nanoparticles Cross-linked Polyetherimide-folic Acid as Efficient Notch-1 siRNA Carrier for Targeted Killing of Breast Cancer

Abstract: In gene therapy, how genetic therapeutics can be efficiently and safely delivered into target tissues/cells remains a major obstacle to overcome. To address this issue, nanoparticles consisting of non-covalently coupled polyethyleneimine (PEI) and folic acid (FA) to the magnetic and fluorescent core/shell of Fe3O4@SiO2(FITC) was tested for their ability to deliver Notch-1 shRNA. Our results showed that Fe3O4@SiO2(FITC)/PEI-FA/Notch-1 shRNA nanoparticles are 64 nm in diameter with well dispersed and superparama… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
38
1
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
2
1

Relationship

2
8

Authors

Journals

citations
Cited by 77 publications
(42 citation statements)
references
References 42 publications
2
38
1
1
Order By: Relevance
“…35 Similarly, Bel-7402 and MCF-7 cells were seeded in 96-well plates and treated with samples with an equivalent concentration of Bru (2 μM). After 24 h, the cells were washed and stained with calcein-AM/PI for 10 min.…”
Section: Apoptosis Assaymentioning
confidence: 99%
“…35 Similarly, Bel-7402 and MCF-7 cells were seeded in 96-well plates and treated with samples with an equivalent concentration of Bru (2 μM). After 24 h, the cells were washed and stained with calcein-AM/PI for 10 min.…”
Section: Apoptosis Assaymentioning
confidence: 99%
“…1,2 However, although siRNA interference is valid, a safe and efficient delivery vector is still a major hurdle to the further development of RNAi therapeutics because of its large molecular weight, strong negative charge, and instability under nuclease and serum proteins, as well as its low transfection efficiency. 3,4 In recent years, interest has grown in developing effective transport carriers to overcome these disadvantages. Due to the fact that they possess…”
Section: Introductionmentioning
confidence: 99%
“…[2][3][4] In particular, designing efficient gene-delivery vectors with low cytotoxicity is considered a major challenge among scientists. 5,6 In clinical trials, viral vectors that have been widely used as gene-delivery carriers have exhibited severe toxicity and caused side effects. 1,2,7 Therefore, there is an increasing demand for the development of nonviral delivery vectors with the ability to overcome physiological barriers.…”
Section: Introductionmentioning
confidence: 99%